The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells.
about
Large animal models of cardiovascular diseaseSignificant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular diseaseNeuronal and nonneuronal cholinergic structures in the mouse gastrointestinal tract and spleenDipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- miceExtracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiationCalcium scoring in patients with a history of Kawasaki disease.Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.Serum sclerostin is an independent predictor of mortality in hemodialysis patientsRelationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study.Association of circulating sclerostin with vascular calcification in Afro-Caribbean men.Osteocyte specific responses to soluble and mechanical stimuli in a stem cell derived culture model.Vascular Calcification and Stone Disease: A New Look towards the Mechanism.Spontaneous Differentiation of Human Mesenchymal Stem Cells on Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold.Arterial Expression of the Calcium-Sensing Receptor Is Maintained by Physiological Pulsation and Protects against Calcification.Mechanisms and clinical consequences of vascular calcificationTreatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism.Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcificationAtherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels.Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro.Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humansSclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women.Intercellular cross-talk among bone cells: new factors and pathways.ATP and arterial calcification.From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.Role and mechanism of action of sclerostin in bone.Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy.Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.Influence of osteocytes in the in vitro and in vivo β-tricalcium phosphate-stimulated osteogenesis.Circulating markers of bone turnover.Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.Sclerostin in Obstructive Sleep Apnea.Upregulation of IGF2 expression during vascular calcification.BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway.
P2860
Q26766350-1E4BD1C7-4D42-427E-AD56-F0F101E5AA64Q26782946-B1FC3700-DA75-40D1-80A5-0FDA225CE602Q33844467-6A304A84-AD88-44BA-9750-1066283FA318Q33883879-C9FEAC6B-46F3-4E7B-8B90-9FF9CF30C128Q34197808-DF5FFFD6-3C5A-4529-A947-6EE70C6F6F5EQ34269222-F2BFBB34-E6CB-45CA-B2A8-4786AAFD9D51Q34300909-7D3199C7-0171-496E-9C80-F6CA919CF378Q34637356-D874F618-6839-4A52-81E7-9B5DCA6C9F93Q34695045-3CF73976-D7C4-4AE9-8710-3E79B46F8E05Q35013412-1D78DE8D-FBF2-4F01-A4A4-4B2653C55BA7Q35091260-3D35500E-1E6B-4241-B8EC-C581678F2281Q35700825-AF058ED3-CC56-4601-AAA6-B21E3423AF4CQ35848058-4EF1F190-3D91-4E6A-86B1-BAA3DD098BF2Q35982861-F6E37CF0-0FBA-4458-A90D-1C06DD8E423BQ36122043-FB9B233A-9AC3-4050-AE79-8B37AFE63A69Q36142207-D12B38DE-5D7D-4A8E-ADB1-5B8AC79BD439Q36193227-3C26AA6E-36B5-4289-A5C6-DB4571AB38F3Q36306725-206C6701-B4C7-4036-B560-1BB36075ABBEQ36582639-10E1620F-8D00-447C-B904-762F5FC61FBBQ36814985-0FE8FDAB-8501-4402-86FD-238790291D2FQ36868287-C13F910F-99B8-42AE-9FC7-CB8EC774D74DQ37123162-BB7F7794-DB3B-4AC6-B300-DC3A82B245C6Q37333243-45914939-6B36-4894-82CC-5E7BCA80A12DQ37423382-66E1FD35-7692-47B2-82AE-25466A61CA85Q37428965-E042FECB-C6A0-4FCF-A0D9-A774452A2F7DQ37428990-AA6A49A9-7A34-41DD-BB44-2F1B11157A94Q37994636-0CF461D1-C256-42C7-AFE8-0AAC8A6C9F7FQ38080569-83725863-AF82-4F20-81FB-D6F026AFCD59Q38367220-C139DE1C-D13B-4367-B800-31A6AC4C2240Q38807230-A928EAFF-308E-4449-9EFB-A1F056CE4C59Q38846381-618A3D87-D10E-4944-B4A7-4B4F6A1E4ACBQ39024329-B8D53285-3E12-477E-8C38-086CA47D810DQ39081849-E750F38D-5A48-478D-8019-5F0A3D2ED1EEQ39304775-EBB200E2-7492-423F-A4FD-40F237C7AA2CQ39342144-9B2F55C5-9B05-4D23-80D2-AE0EF6B01776Q40031994-98CECF3A-BE6A-404F-BF85-13BD4351CDEAQ40760789-AD4390E5-D256-4AEB-8C36-CFA528363877Q40945270-ED9A8617-6E41-4A28-952E-89793AD8F7F1Q41697749-091C399B-B528-4198-B0FF-2642CFF8AB6EQ41781589-41E95412-C264-4AF6-83D3-ECDED653469E
P2860
The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The appearance and modulation ...... vascular smooth muscle cells.
@ast
The appearance and modulation ...... vascular smooth muscle cells.
@en
type
label
The appearance and modulation ...... vascular smooth muscle cells.
@ast
The appearance and modulation ...... vascular smooth muscle cells.
@en
prefLabel
The appearance and modulation ...... vascular smooth muscle cells.
@ast
The appearance and modulation ...... vascular smooth muscle cells.
@en
P2860
P50
P1433
P1476
The appearance and modulation ...... vascular smooth muscle cells.
@en
P2093
José Luis Millán
Neil Charles Wallace Mackenzie
P2860
P304
P356
10.1371/JOURNAL.PONE.0019595
P407
P577
2011-05-17T00:00:00Z